Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Apr;7(Suppl 2):S146-S148.
doi: 10.21037/tlcr.2018.03.13.

Precision radiotherapy for patients with locally advanced non-small cell lung cancer in the era of immunotherapy and precision medicine

Hidehito Horinouch  1
Affiliations
Editorial

Precision radiotherapy for patients with locally advanced non-small cell lung cancer in the era of immunotherapy and precision medicine

Hidehito Horinouch. Transl Lung Cancer Res. 2018 Apr.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: H Horinouchi has received research and development fund from MSD, Merck serono, BMS, Ono, Astellas, Novartis, Chugai and TAIHO Pharmaceuticals. And he has received honoraria from Eli Lilly, TAIHO Pharmaceuticals, BMS, Ono, Novartis, AstraZeneca, Kyowa-Kirin, Daiichi-Sankyo and Chugai.

Comment on

References

    1. Roswit B, Patno ME, Rapp R, et al. The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. Radiology 1968;90:688-97. 10.1148/90.4.688 - DOI - PubMed
    1. Perez CA, Stanley K, Rubin P, et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 1980;45:2744-53. 10.1002/1097-0142(19800601)45:11<2744::AID-CNCR2820451108>3.0.CO;2-U - DOI - PubMed
    1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899-909. 10.1136/bmj.311.7010.899 - DOI - PMC - PubMed
    1. Segawa Y, Kiura K, Takigawa N, et al. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007. J Clin Oncol 2010;28:3299-306. 10.1200/JCO.2009.24.7577 - DOI - PubMed
    1. Yamamoto N, Nakagawa K, Nishimura Y, et al. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105. J Clin Oncol 2010;28:3739-45. 10.1200/JCO.2009.24.5050 - DOI - PubMed

LinkOut - more resources